Who should be liable for funding recombinant factor VIII?

被引：0
|
作者：
Richards, RG [1 ]
机构：
[1] N Nottinghamshire Hlth Author, Nottingham NG21 0ER, England
来源：
BRITISH MEDICAL JOURNAL | 1998年 / 316卷 / 7141期
关键词：
D O I：
10.1136/bmj.316.7141.1385a
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1385 / 1386
页数：2
相关论文
共 50 条
  • [1] Who should receive recombinant factor VIII?
    Giangrande, PLF
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 : S25 - S27
  • [2] WHO SHOULD USE RECOMBINANT FACTOR-VIII
    HOOTS, K
    [J]. ANNALS OF HEMATOLOGY, 1994, 68 : S65 - S68
  • [3] THE TORTS OF THE INTOXICATED - WHO SHOULD BE LIABLE
    KOLOFF, KN
    [J]. COLUMBIA JOURNAL OF LAW AND SOCIAL PROBLEMS, 1979, 15 (01): : 33 - 60
  • [4] WHO SHOULD BE LIABLE FOR THE COVID-19 OUTBREAK?
    Perry, Ronen
    [J]. HARVARD JOURNAL ON LEGISLATION, 2021, 58 (02) : 253 - 312
  • [5] Celebrity endorsements in medicine: who should be held liable?
    Kumar, Rajeev
    [J]. INDIAN JOURNAL OF UROLOGY, 2016, 32 (03) : 171 - +
  • [6] Recombinant Factor VIII Concentrates
    Franchini, Massimo
    Lippi, Giuseppe
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2010, 36 (05): : 493 - 497
  • [7] Should hemophilia treaters switch to albumin-free recombinant factor VIII concentrates
    Meeks, Shannon L.
    Josephson, Cassandra D.
    [J]. CURRENT OPINION IN HEMATOLOGY, 2006, 13 (06) : 457 - 461
  • [8] THE PROPERTIES OF FACTOR-VIII IN THE RECOMBINANT FACTOR-VIII CONCENTRATES
    TANAKA, I
    YOSHIOKA, A
    SHIMA, M
    FUJIWARA, T
    TERADA, S
    NAKAI, H
    SAWAMOTO, Y
    KAMISUE, S
    FUKUI, H
    [J]. THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 209 - 209
  • [9] Funding Should Come to Those Who Wait
    Swaisgood, Ronald R.
    Terborgh, John W.
    Blumstein, Daniel T.
    [J]. SCIENCE, 2010, 329 (5989) : 276 - 276
  • [10] Who should be given priority for public funding?
    Bae, Eun-Young
    Lim, Min Kyoung
    Lee, Boram
    Bae, Green
    [J]. HEALTH POLICY, 2020, 124 (10) : 1108 - 1114
12345